Toll-like receptors in inflammatory bowel diseases: a decade later
- PMID: 20803699
- PMCID: PMC2958454
- DOI: 10.1002/ibd.21282
Toll-like receptors in inflammatory bowel diseases: a decade later
Abstract
Differential alteration of Toll-like receptor (TLR) expression in inflammatory bowel disease (IBD) was first described 10 years ago. Since then, studies from many groups have led to the current concept that TLRs represent key mediators of innate host defense in the intestine, involved in maintaining mucosal as well as commensal homeostasis. Recent findings in diverse murine models of colitis have helped to reveal the mechanistic importance of TLR dysfunction in IBD pathogenesis. It has become evident that environment, genetics, and host immunity form a multidimensional and highly interactive regulatory triad that controls TLR function in the intestinal mucosa. Imbalanced relationships within this triad may promote aberrant TLR signaling, critically contributing to acute and chronic intestinal inflammatory processes in IBD colitis and associated cancer.
Figures
Similar articles
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.J Immunol Res. 2015;2015:489821. doi: 10.1155/2015/489821. Epub 2015 May 18. J Immunol Res. 2015. PMID: 26090491 Free PMC article. Review.
-
Role of toll-like receptors in inflammatory bowel disease.Pharmacol Res. 2018 Mar;129:204-215. doi: 10.1016/j.phrs.2017.11.017. Epub 2017 Nov 16. Pharmacol Res. 2018. PMID: 29155256 Review.
-
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?Clin Exp Immunol. 2016 Mar;183(3):358-68. doi: 10.1111/cei.12732. Epub 2015 Nov 26. Clin Exp Immunol. 2016. PMID: 26462859 Free PMC article.
-
Toll-like Receptors and Inflammatory Bowel Disease.Front Immunol. 2018 Jan 30;9:72. doi: 10.3389/fimmu.2018.00072. eCollection 2018. Front Immunol. 2018. PMID: 29441063 Free PMC article. Review.
Cited by
-
Biosynthetic enzyme analysis identifies a protective role for TLR4-acting gut microbial sulfonolipids in inflammatory bowel disease.Nat Commun. 2024 Oct 30;15(1):9371. doi: 10.1038/s41467-024-53670-y. Nat Commun. 2024. PMID: 39477928 Free PMC article.
-
Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2.Gut Microbes. 2024 Jan-Dec;16(1):2387857. doi: 10.1080/19490976.2024.2387857. Epub 2024 Aug 22. Gut Microbes. 2024. PMID: 39171684 Free PMC article.
-
Sea Buckthorn Polysaccharide Ameliorates Colitis.Nutrients. 2024 Apr 25;16(9):1280. doi: 10.3390/nu16091280. Nutrients. 2024. PMID: 38732527 Free PMC article.
-
Hydrogen Regulates Ulcerative Colitis by Affecting the Intestinal Redox Environment.J Inflamm Res. 2024 Feb 12;17:933-945. doi: 10.2147/JIR.S445152. eCollection 2024. J Inflamm Res. 2024. PMID: 38370464 Free PMC article. Review.
-
Cinnamic Acid Ameliorates Acetic Acid-induced Inflammatory Response through Inhibition of TLR-4 in Colitis Rat Model.Antiinflamm Antiallergy Agents Med Chem. 2024;23(1):21-30. doi: 10.2174/0118715230278980231212103709. Antiinflamm Antiallergy Agents Med Chem. 2024. PMID: 38361356
References
-
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–434. - PubMed
-
- Janeway CA, Jr, Goodnow CC, Medzhitov R. Danger — pathogen on the premises! Immunological tolerance. Curr Biol. 1996;6:519–522. - PubMed
-
- Medzhitov R, Preston-Hurlburt P, Janeway CA., Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394–397. - PubMed
-
- Poltorak A, Smirnova I, He X, et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis. 1998;24:340–355. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources